Farlow MR, Grossberg GT, Sadowsky CH, Meng X, Velting DM. A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer Disease. Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):110-6. PubMed.
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.